eedq has been researched along with yohimbine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nowak, G; Pilc, A; Zak, J | 1 |
| Biggio, G; Giorgi, O | 1 |
| Enna, SJ; Nomura, S; Pilc, A; Vetulani, J | 1 |
| Oriowo, MA | 1 |
| Fujinaga, M; Golden, W; Guo, TZ; Maze, M; Poree, L; Stein, J | 1 |
| Coupar, IM; Liu, L | 1 |
| Carbonell, L; Cuffí, ML; Forn, J | 1 |
7 other study(ies) available for eedq and yohimbine
| Article | Year |
|---|---|
N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible receptor inactivator, as a tool for measurement of alpha 2-adrenoceptor occupancy in vivo.
Topics: Adrenergic alpha-Antagonists; Animals; Cerebral Cortex; Clonidine; Male; Quinolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1992 |
Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Ergolines; Ketanserin; Male; Motor Activity; Prazosin; Quinolines; Quinpirole; Raclopride; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Salicylamides; Yohimbine | 1990 |
An in vivo procedure for the selective inactivation of rat brain cerebral cortical alpha-adrenoceptors using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Topics: Adrenergic alpha-Antagonists; Animals; Cell Membrane; Cerebral Cortex; Clonidine; Cyclic AMP; Dihydroalprenolol; Inositol Phosphates; Isoproterenol; Male; Norepinephrine; Prazosin; Quinolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1989 |
The prejunctional inhibitory effect of alpha-methylnoradrenaline in the rat vas deferens is not mediated via alpha 2-adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Clonidine; Dioxanes; Electric Stimulation; Idazoxan; Imidazoles; Isometric Contraction; Male; Neuromuscular Junction; Nordefrin; Phenoxybenzamine; Phentolamine; Quinolines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Adrenergic, alpha-2; Vas Deferens; Vasoconstrictor Agents; Yohimbine | 1995 |
Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat.
Topics: Adrenergic alpha-Antagonists; Analgesics; Analgesics, Non-Narcotic; Animals; Imidazoles; Male; Naloxone; Narcotic Antagonists; Nitrous Oxide; Nociceptors; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid; Spinal Cord; Yohimbine | 1996 |
Involvement of alpha-2 adrenoceptors in the effects of moxonidine on intestinal motility and fluid transport.
Topics: Adrenergic alpha-2 Receptor Agonists; Agmatine; Animals; Body Water; Brimonidine Tartrate; Dose-Response Relationship, Drug; Gastrointestinal Motility; Imidazoles; Male; Peristalsis; Quinolines; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Vasoactive Intestinal Peptide; Yohimbine | 1997 |
Effect of chronic lithium treatment on the turnover of alpha2-adrenoceptors after chemical inactivation in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Algorithms; Animals; Cerebral Cortex; Half-Life; Lithium; Male; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Yohimbine | 2004 |